Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease IM Wahba, RH Mak Clinical journal of the American Society of Nephrology 2 (3), 550-562, 2007 | 745 | 2007 |
Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature IM Wahba, EL Simpson, K White American Journal of Transplantation 7 (10), 2425-2432, 2007 | 116 | 2007 |
Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice CW Yang, GR Faulkner, IM Wahba, TA Christianson, GC Bagby, DC Jin, ... American Journal of Transplantation 2 (5), 391-399, 2002 | 99 | 2002 |
Risks and options with gadolinium-based contrast agents in patients with CKD: a review MR Rudnick, IM Wahba, AK Leonberg-Yoo, D Miskulin, HI Litt American Journal of Kidney Diseases 77 (4), 517-528, 2021 | 59 | 2021 |
The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy—report of two cases and review of the literature IM Wahba, K White, M Meyer, EL Simpson Nephrology Dialysis Transplantation 22 (2), 631-636, 2007 | 38 | 2007 |
Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis A Deodhar, E Allen, K Daoud, I Wahba Seminars in arthritis and rheumatism 32 (1), 3-9, 2002 | 36 | 2002 |
Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen OHK Mohamed, IM Wahba, S Watnick, SB Earle, WM Bennett, JW Ayres, ... Clinical Journal of the American Society of Nephrology 2 (4), 694-699, 2007 | 28 | 2007 |
Intra-abdominal hypertension is an under-appreciated cause of acute renal failure Y Shibagaki, C Tai, A Nayak, I Wahba Nephrology Dialysis Transplantation 21 (12), 3567-3570, 2006 | 24 | 2006 |
Fluid administration strategies for the prevention of contrast-associated acute kidney injury MR Rudnick, K Fay, IM Wahba Current opinion in nephrology and hypertension 31 (5), 414-424, 2022 | 15 | 2022 |
Finding a common language for patient safety in CKD JC Fink, MS Joy, WLS Peter, IM Wahba, ... Clinical Journal of the American Society of Nephrology 7 (4), 689-695, 2012 | 13 | 2012 |
Increased vascular resistance and not salt retention characterizes cyclosporine A–induced hypertension: Report in an anuric patient IM Wahba, WM Bennett American journal of transplantation 7 (8), 2042-2046, 2007 | 11 | 2007 |
Acute kidney injury due to pulmonary embolism: the case for ‘congestive renal failure’ S Dadfarmay, IM Wahba Nephrology Dialysis Transplantation Plus 4 (5), 295-298, 2011 | 5 | 2011 |
Prevalence of Chronic Kidney Disease in Patients with Pulmonary Arterial Hypertension. JC Cedergreen, CJ Markin, IM Wahba C63. DETERMINANTS OF PULMONARY HYPERTENSION OUTCOMES, A4864, 2009 | 3 | 2009 |
Handling of drugs in children with abnormal renal function IM Wahba, AJ Olyaei, D Rozansky, WM Bennett Pediatric Nephrology, 2009 | 3 | 2009 |
Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced kidney disease MR Rudnick, I Wahba, FD Miskulin UpToDate, Literature review current through Oct, 2024 | 1 | 2024 |
Use of gadolinium-based contrast agents in patients with severe renal impairment. absence of risk versus caution: a nephrologist’s perspective MR Rudnick, IM Wahba, AK Leonberg-Yoo Kidney360 1 (6), 433-435, 2020 | 1 | 2020 |
IMPORTANCE OF MAP REDUCTION FOR AKI INDUCTION IN TYPE 1 CARDIORENAL SYNDROME A Pennekamp, I Wahba AMERICAN JOURNAL OF KIDNEY DISEASES 81 (4), S39-S39, 2023 | | 2023 |
Authors Reply to: Gadolinium Exposure in Organ Donors May Cause Nephrogenic Systemic Fibrosis in Transplant Recipients Never Exposed to Gadolinium IM Wahba, EL Simpson, K White American Journal of Transplantation 8 (5), 1076, 2008 | | 2008 |
Imaging agents CM Erley, IM Wahba, GA Porter Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals, 699-724, 2008 | | 2008 |
Nephrogenic systemic fibrosis (first report with prednisone, tacrolimus and mycophenolate mofetil) after organ transplantation: 2 case reports IM Wahba Reactions 1169, 15, 2007 | | 2007 |